Abstract

In the cardiovascular system, the bioactive lipid sphingosine‐1‐phosphate (S1P) exerts its vasoactive effects predominantly via the S1P1, S1P2 and S1P3 receptor which are differentially expressed in vascular smooth muscle cells (VSMCs) and endothelial cells (ECs).We have explored the contribution of these three receptors to vascular reactivity in rat aorta and to related signaling mechanisms in isolated VSMCs and ECs using some new S1P receptor ligands. In rat aortic rings, all agonists at the S1P1 and/or S1P3 receptor induced endothelium‐dependent vasorelaxation in pre‐contracted preparations. In rat aortic ECs, which showed a high mRNA expression of the Gi‐coupled S1P1 receptor, all ligands decreased the forskolin‐induced cAMP accumulation whereas no major changes in [Ca2+]i were observed. In VSMCs, which express mRNA for all three S1P receptors, predominantly Gq‐coupled S1P2 receptor signaling was observed, resulting in increases in [Ca2+]i.In conclusion, the compounds tested in this study can act on both ECs and VSMCs from rat aorta. S1P1 receptor stimulation in ECs leads to Gi activation probably resulting in relaxation via activation of PI3K/Akt and subsequent NO production. Stimulation of mainly the S1P2 receptor in VSMCs results in calcium elevation, a response typically linked to contraction. For agonists devoid of S1P2 activity, the net effect observed on aortic tone is thus vasorelaxation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.